Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Asset Utilization Ratio (2020 - 2025)

Ovid Therapeutics' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.07 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 1242.45% year-over-year to 0.07; the TTM value through Dec 2025 reached 0.07, up 1242.45%, while the annual FY2025 figure was 0.06, 1144.87% up from the prior year.
  • Asset Utilization Ratio reached 0.07 in Q4 2025 per OVID's latest filing, down from 0.09 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 2.14 in Q4 2021 to a low of 0.01 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 1.14, with a median of 1.35 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: surged 1319.49% in 2021, then tumbled 99.7% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 2.14 in 2021, then plummeted by 34.76% to 1.4 in 2022, then grew by 18.85% to 1.66 in 2023, then plummeted by 99.7% to 0.01 in 2024, then skyrocketed by 1242.45% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for OVID's Asset Utilization Ratio are 0.07 (Q4 2025), 0.09 (Q3 2025), and 0.08 (Q2 2025).